Form 4: Jazz Pharmaceuticals CEO Renee Gala Donates Shares

Jazz Pharmaceuticals CEO Renee Gala donated 600 ordinary shares to a donor-advised fund on June 3, 2026.

Summary

• CEO Renee D. Gala disposed of 600 ordinary shares of Jazz Pharmaceuticals plc.
• The transaction was a gift (Code G) with a price of $0.0.
• The shares were donated to The Gala Family Fund, a donor-advised fund.
• Following the transaction, the reporting person beneficially owns 152,196 ordinary shares.
• The reporting person also acquired 166 ordinary shares via an Employee Stock Purchase Plan on May 29, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction represents a charitable donation rather than a divestment of shares for liquidity or market-based reasons.

Positives

• The CEO maintains a significant equity stake of 152,196 shares in the company.

Negatives

• None identified; this is a charitable donation rather than a market sale.

Risks

• None identified.

Future Outlook

Not applicable.

Industry Context

StockSavvy.ai notes that insider charitable donations are common executive wealth management activities and generally do not signal a lack of confidence in the company's future performance.

Comparison to Industry Standards

• The transaction is consistent with standard executive equity management practices in the pharmaceutical sector.

Related Party Transactions

• Donation of 600 shares to The Gala Family Fund, a donor-advised fund.

Stakeholder Impact

• No material impact on shareholders or company operations.

Next Steps

• None.

Key Dates

Keywords

Jazz Pharmaceuticals, JAZZ, Insider Trading, Form 4, Renee Gala, Equity Ownership